Value Proof, Portfolio Decisions & Misdiagnosis Risks
Value Proof, Portfolio Decisions & Misdiagnosis Risks governs the strength of a value claim. Claims progress through claimed, operational, measured, attributed and sustained evidence. Reviews test blind spots, incentives and alternative explanations before recommending Kill, Pivot, Persevere, Scale or Sunset.
Use value evidence to decide whether AI initiatives should continue, change, scale or stop. Separate weak proof from problems in strategy, data or delivery.
Explore the holistic AIDIVE frameworkWhy this matters
Large forecasts and enthusiastic anecdotes can outrun proof; early setbacks can also prompt an unjustified rejection. Commitment and claim language should reflect the current evidence and its limits.
Questions to bring to the work
- What is the strongest claim the evidence currently supports?
- Could another change, an omitted group or a flawed denominator reverse our conclusion?
Explore this chapter
I.6.1Evidence Ladder and Value Proof GapsClassify claims as claimed, operational, measured, attributed or sustained; keep evidence confidence separate from forecast size and close explicit proof gaps.
I.6.2Measurement Blind Spots & Perverse IncentivesInspect missing cases, denominators, counter-metrics and incentives to detect gaming, displaced burden or apparent improvement without outcome improvement.
I.6.3False Positives, False Negatives & Attribution ErrorsTest alternative explanations and distinguish model, process, data, adoption and transition effects before crediting or rejecting the human–AI configuration.
I.6.4Kill, Pivot, Persevere, Scale & Sunset DecisionsUse evidence to recommend Kill, Pivot, Persevere, Scale or Sunset, with criteria set before review and closure obligations preserved.
I.6.5Claim Integrity and Premature RejectionState for whom, where, against what comparison and at what cost the effect occurred; revise claims as contrary evidence or context changes.
What useful evidence looks like
- A claim-to-evidence register with scope, comparator, costs, uncertainty and proof gaps.
- Gate records showing the criteria, confidence, downside, recommendation and resulting resource decision.
Move from understanding to practice
AR-IM16AR-IM16 · Portfolio Allocation and ROAI Confidence Calibration
AR-IM21AR-IM21 · Re-prioritisation Triggers
AR-IM25AR-IM25 · Value Proof, Attribution and Misdiagnosis Review
Framework source
Editorial adaptation from the supplied AIDIVE Version 1 master documents.
- AIDIVE Impact Dimension Version-1.docx · I.6 Value Proof, Portfolio Decisions & Misdiagnosis Risks; AIDIVE Impact - Practices & Playbook Version-1.docx · AR-IM16, AR-IM21, AR-IM25
Impact
Dimension overview ↗01Strategic Value Intent & Outcome Design02Multi-Dimensional Value Model03AI Economics & Business Case Logic04Measurement, Attribution & Decision Feedback Loops05Scaling Value & Benefits Realization Across the Enterprise06Value Proof, Portfolio Decisions & Misdiagnosis RisksFind a practiceLEARN. CONTRIBUTE. APPLY.Put AI transformation
into practice.
Build capability through training, contribute your expertise or explore a connected workspace for applying the holistic AIDIVE framework.
TRAINING & CERTIFICATIONBuild the capability.
Develop the skills to connect AI transformation strategy, business outcomes, people and governance to your own decisions and responsibilities.
Explore AI Transformation StrategistFind class dates across all providers ↗PARTNER WITH AIDIVEGrow the practice.
Bring your learning, delivery or research expertise to the holistic AIDIVE approach to enterprise AI transformation.
Explore partnership routesAIDIVE PLATFORMBring AIDIVE into your work.
See how the proposed workspace could connect AI transformation learning, maturity evidence and practical artifacts.
Explore the platform conceptCONNECT THE DOTS